Key account management excellence in pharma & medtech / (Record no. 33454)

MARC details
000 -LEADER
fixed length control field 01769nam a2200217Ia 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260718102836.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 230508s2022 xx 000 0 und d
050 ## - LIBRARY OF CONGRESS CALL NUMBER
Classification number Allied HD 9665.5
Item number K48 2022
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Moorman, Mike
245 10 - TITLE STATEMENT
Title Key account management excellence in pharma & medtech /
Statement of responsibility, etc. Mike Moorman.
264 ## - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture London :
Name of producer, publisher, distributor, manufacturer Routledge,
Date of production, publication, distribution, manufacture, or copyright notice 2022.
300 ## - PHYSICAL DESCRIPTION
Extent xxv, 216 pages ;
Dimensions 24 cm.
500 ## - GENERAL NOTE
General note Includes index
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note ch. 1. Kam is a business strategy, not a role — ch. 2. The rise of the organized customer and kam in healthcare — ch. 3. Where to play: key account segmentation and selection — ch. 4. Value strategy: evolving from basic offerings to advanced solutions — ch. 5. Kam organization design: form follows function — ch. 6. Executive alignment and engagement: its make or break for life sciences kam program — ch. 7. Kam program office: marshalling the internal support required for results — ch. 8. The long and short of kam matrics — ch. 9. Customer engagement process: the secret to agile execution — ch. 10. Bringing value to account planning and management — ch. 11. Context is king: laying the foundation for a comprehensive kam talent strategy — ch. 12. The unique learning journey required for kam — ch. 13. Key account manager incentive compensation: aligning to strategic objectives — ch. 14. Why technology is critical for breathing life into kam — ch. 15. Kam in the United States versus Europe: are we headed to the same place? — ch. 16. The future of kam in life science.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical industry
General subdivision Management
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medical supplies industry
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Marketing
General subdivision Key accounts
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Customer services
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Books
Call number prefix EAC Cavite-Allied Health Sciences Section
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Cost, normal purchase price Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    Library of Congress Classification     EAC Library Cavite EAC Library Cavite EAC Cavite-Allied Health Sciences Section 05/16/2023 4041.00   Allied HD 9665.5 K48 2022 ML16623 05/29/2026 05/16/2023 Books